Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01452854 · ClinicalTrials.gov registry record
Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide
A clinical trial, sponsored by University of California, San Francisco.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01452854: Clinical Trial study, sponsored by University of California, San Francisco.
NCT01452854 is a clinical trial that was terminated before completion, run by University of California, San Francisco. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01452854 was terminated before completion, sponsored by University of California, San Francisco.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to look at how a chemotherapy treatment (Temozolomide, also called Temodar) affects the process of ovarian aging which is measured by a decline in ovarian follicle count, in patients with Low Grade Glioma (LGG). It is important to know if different patient factors and Temozolomide influence the rate of ovarian aging in women with LGG who have good long-term survival rates. This will allow better counseling about the effects of this particular chemotherapy agent on fertility in women.
Primary Outcome
Transvaginal Ultrasound will be use to measure Antral Follicle Counts (AFC) and blood will be drawn to measure hormones (FSH, LH, estradiol, estrone, AMH, SHBG, testosterone, and inhibin B).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2011-10 |
| Est. Completion | 2013-11 |
Why NCT01452854 stopped before completion
NCT01452854 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 2 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01452854 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01452854 about?
NCT01452854 is a clinical study titled "Ovarian Aging in Low Grade Glioma (LGG) Treated With Temozolomide". The purpose of this study is to look at how a chemotherapy treatment (Temozolomide, also called Temodar) affects the process of ovarian aging which is measured by a decline in ovarian follicle count, in patients with Low Grade Glioma (LGG). It is important to know if different patient factors and Te...
What is the current status of trial NCT01452854?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2011-10. Estimated completion is 2013-11.
Who is sponsoring clinical trial NCT01452854?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia